Novartis Cosentyx helps improve painful skin disorder in 2 phase 3 trials
Novartis (NVS) said on Sept. 10 that its medicine Cosentyx showed superior efficacy, compared to placebo, with statistically significant improvement in symptoms of a skin disease in…
Novartis Cosentyx helps improve painful skin disorder in 2 phase 3 trials
Novartis (NVS) said on Sept. 10 that its medicine Cosentyx showed superior efficacy, compared to placebo, with statistically significant improvement in symptoms of a skin disease in…